Expertise in Immunogenicity Assessment
Immunogenicity influences safety and efficacy of biologic drugs, with consequences ranging up to life-threatening reactions.Celerion has over 30 years’ experience in immunogenicity assessment using various immunoanalytical and cell-based technologies, one of the pioneers of immunogenicity testing from the mid-1990s.
Sensitivity Drives Multi-tier Immunogenicity Platform Selection
Immunogenicity platforms are varied and plentiful, but possess a spectrum of advantages all driven by the particular biologic’s unique characteristics and development needs. The Celerion ScienceTM Team creates immunogenicity strategies across the drug development lifecyle in a customized, adaptive manner.